- Home
- BEEP vs GNLX Comparison
BEEP vs GNLX Comparison
Compare BEEP & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEEP
- GNLX
- Stock Information
- Founded
- BEEP 2015
- GNLX 2001
- Country
- BEEP United States
- GNLX United States
- Employees
- BEEP N/A
- GNLX N/A
- Industry
- BEEP Blank Checks
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- BEEP Finance
- GNLX Health Care
- Exchange
- BEEP Nasdaq
- GNLX Nasdaq
- Market Cap
- BEEP 128.3M
- GNLX 103.6M
- IPO Year
- BEEP N/A
- GNLX 2023
- Fundamental
- Price
- BEEP $3.21
- GNLX $2.76
- Analyst Decision
- BEEP
- GNLX Strong Buy
- Analyst Count
- BEEP 0
- GNLX 4
- Target Price
- BEEP N/A
- GNLX $18.75
- AVG Volume (30 Days)
- BEEP 66.1K
- GNLX 157.7K
- Earning Date
- BEEP 11-12-2024
- GNLX 11-19-2024
- Dividend Yield
- BEEP N/A
- GNLX N/A
- EPS Growth
- BEEP N/A
- GNLX N/A
- EPS
- BEEP N/A
- GNLX N/A
- Revenue
- BEEP $35,743,000.00
- GNLX $8,000.00
- Revenue This Year
- BEEP N/A
- GNLX N/A
- Revenue Next Year
- BEEP N/A
- GNLX N/A
- P/E Ratio
- BEEP N/A
- GNLX N/A
- Revenue Growth
- BEEP 15.04
- GNLX N/A
- 52 Week Low
- BEEP $2.48
- GNLX $1.60
- 52 Week High
- BEEP $6.30
- GNLX $16.60
- Technical
- Relative Strength Index (RSI)
- BEEP 51.05
- GNLX 48.88
- Support Level
- BEEP $2.75
- GNLX $2.86
- Resistance Level
- BEEP $3.60
- GNLX $3.03
- Average True Range (ATR)
- BEEP 0.20
- GNLX 0.27
- MACD
- BEEP 0.04
- GNLX -0.03
- Stochastic Oscillator
- BEEP 54.12
- GNLX 35.51
About BEEP Mobile Infrastructure Corporation
Mobile Infrastructure Corp focuses on acquiring, owning, and leasing parking facilities and related infrastructure, including parking lots, parking garages and other parking structures throughout the United States. The company owns forty three parking facilities in twenty one separate markets throughout the United States, with a total of approximately fifteen thousand seven hundred parking spaces. The company derives majority of revenue from Percentage rental income.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.